Navigation Links
Studies challenge standards to improve treatment outcomes for patients with clotting disorders
Date:12/8/2012

re liberal approach (keeping hematocrit levels between 45 and 50%), investigators from Italy conducted a study comparing the two strategies among 365 patients with newly diagnosed PV. Patients in Arm A were treated aggressively to maintain hematocrit levels at less than 45 percent, while the patients in Arm B were treated to maintain levels between 45 and 50 percent. The primary composite endpoint was major clots, including stroke, heart attack, transient ischemic attacks ("mini strokes"), clots in the veins in the abdomen, DVT or PE, and cardiovascular death.

The investigators observed that the risk of developing major clots was four times higher in those patients whose hematocrit levels were kept between 45 and 50 percent than in patients whose levels were kept below 45 percent. With the more intensive regimen in Arm A, 1.1 percent of the patients had a major clot versus 4.4 percent in the less aggressive regimen in Arm B. The median hematocrit levels during follow-up were 44 percent and 48 percent, respectively. Treatment with phlebotomy, anti-clotting drugs, and hydroxyurea were comparable.

There was no difference in the safety profile between the regimens. Six patients in Arm A and one patient in Arm B developed myelofibrosis, a blood disorder that causes the bone marrow to be replaced by scar tissue. Researchers observed no statistical difference in the frequency of acute leukemias that occurred in three patients in Arm A and one patient in Arm B.

"These data validate the notion that it is important to keep hematocrit levels below 45 percent for this population of patients who are at a high risk of developing clotting complications," said Tiziano Barbui, MD, lead author and Professor of Hematology and Scientific Director of the Research Foundation at Ospedali Riuniti di Bergamo in Italy. "The results from our study will be especially important in the development of new drugs for polycythemia vera, as we look to maintain these leve
'/>"/>

Contact: Andrea Slesinski
aslesinski@hematology.org
614-352-5096
American Society of Hematology
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Studies assess genetics, modified treatment to improve outcomes, reduce toxicity
2. John Theurer Cancer Center to present 37 studies at the 2012 ASH Annual Meeting
3. Benefit6 Whole Body Protection, a New Product by I Do Strive LLC, Provides Increased Energy Production According to Recent Studies
4. Sharp spike in computer-related injuries predicted for medical workers, find studies
5. Analysis of conflicting fish oil studies finds that omega-3 fatty acids still matter
6. Studies from 2012 Quality Care Symposium highlight findings in improving quality of cancer care
7. New studies show effects of mammography guideline changes
8. 2 NIH studies show power of epidemiology research; Underscore need to address health disparities
9. Scripps studies show community-based diabetes programs are key to lowered costs and improved care
10. Cancer Drug Reduced Relapses in MS Patients: Studies
11. University of Houston India Studies Program presents Circuits of Empire: India as Metropole
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2014)... News) -- The holidays can be a challenge for ... trigger major meltdowns, an expert says. "Holidays with ... but when you have children with special needs, some ... professor at University of the Sciences in Philadelphia, said ... let your hosts or visitors know what special requirements ...
(Date:11/23/2014)... To show thanks to new and old customers, iFitDress.com ... dresses for weddings. Customers who need custom outfits can ... distinguished dress manufacturer, and it is among the ones which ... very long time. The CEO of this company says, "iFitDress.com ... to buy not only a beautiful dress, but also a ...
(Date:11/23/2014)... AngelWeddingDress.com has recently updated ... of beach wedding dresses. “If you are looking for ... as soon as possible. Here you can enjoy 70% ... says. , Holding a big marriage ceremony is the ... beautiful beach wedding dress is uppermost priority. Ophelia, one ...
(Date:11/23/2014)... 2014 The FDA is Watching: , ... On-Demand Webinar**, Dec. 11, 2014 ? Any Time at ... focus on promotional activities is no longer limited to ... looking at websites, Twitter, journal articles, TV appearances, Facebook ... Dec. 11, for On-Demand access to Timothy Ayers and ...
(Date:11/23/2014)... November 23, 2014 BambooFlooringChina.com , the ... click strand woven bamboo flooring collection. Now, the ... to the company’s CEO, the promotion is valid until Dec. ... comes with a smooth and dust-free surface, which makes it ... in the industry, the company wants to make its website ...
Breaking Medicine News(10 mins):Health News:Holidays Can Be Sensory Overload for Kids With Autism 2Health News:iFitDress.com: Wonderful White Evening Dresses Now Available 2Health News:Beach Wedding Dresses Added to Outstanding Online Dress Company AngelWeddingDress.com 2Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 2Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 3Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 4Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 5Health News:Click Strand Woven Bamboo Flooring From Famous Bamboo Flooring Company BambooFlooringChina.com 2
... By Kathleen Doheny HealthDay Reporter , FRIDAY, ... overweight or obese tend to befriend and date people ... The finding echoes previous research that found health ... study author Dr. Tricia M. Leahey, an assistant professor ...
... , FRIDAY, Jan. 14 (HealthDay News) -- Riding in a convertible ... warns. U.S. researchers conducted sound level measurements using five different ... noise levels were above 85 decibels (dB) when the top was ... (mph) or faster. Exposure to noise levels above 85 dB ...
... News) -- Among older adults who,ve recently had a ... to take medications meant to prevent another heart attack, ... Harvard Medical School researchers and colleagues analyzed the pharmacy ... who recently had a heart attack and were prescribed ...
... By Jenifer Goodwin HealthDay Reporter , FRIDAY, Jan. ... in love? Ever feel like the passing years, the never-ending ... have quashed your infatuation for your spouse? New ... to that passion and romance for decades or more. ...
... Amanda Gardner HealthDay Reporter , THURSDAY, Jan. ... that they will lower the maximum amount of the ... as Vicodin and Percocet because of reports of severe ... the upper threshold of acetaminophen in prescription drugs containing ...
... E. coli uses a laser to detect and monitor ... The technique described this month in the International Journal ... incidence of waterborne disease outbreaks. Microbial contamination of water ... are the leading causes of illness and death in the ...
Cached Medicine News:Health News:Overweight Young Adults Often Have Overweight Friends, Sweethearts 2Health News:Overweight Young Adults Often Have Overweight Friends, Sweethearts 3Health News:Riding With the Top Down May Put Hearing at Risk 2Health News:Heart Attack Patients With Kidney Problems Often Skip Meds 2Health News:Brain Scans Show Married Love Can Last 2Health News:Brain Scans Show Married Love Can Last 3Health News:FDA Lowers Amount of Acetaminophen Allowed in Prescription Painkillers 2Health News:FDA Lowers Amount of Acetaminophen Allowed in Prescription Painkillers 3Health News:Speeding up E. coli detection 2
(Date:11/21/2014)...  Heated dialogue in recent months about the rising ... to Gilead,s new hepatitis C drug Harvoni® – has ... what it means to put a price on patient ... while drug pricing is one of the most debated ... general business and ethical standpoint – it is also ...
(Date:11/21/2014)... , 21. November 2014 ... heute bekannt gegeben, dass die Europäische ... die Kennzeichnung als Orphan-Medizinprodukt an Palovarotene ... Unternehmens zur Behandlung von Fibrodysplasia ossificans ... stark beeinträchtigende genetische Krankheit, die von ...
(Date:11/21/2014)... 20, 2014  Edwards Lifesciences Corporation (NYSE: ... heart valves and hemodynamic monitoring, announced today that it ... support a strong launch of Edwards Lifesciences Foundation,s new ... improve the global communities where its employees live and ... giving will exceed $8 million, including more than $7 ...
Breaking Medicine Technology:"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 3"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 4"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 5Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3Edwards Lifesciences Increases Charitable Giving In 2014 To Support Launch Of Every Heartbeat Matters 2
The K-ASSAY Rheumatoid Factor Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assay for quantifying...
... Urine Controls are supplied as ... requiring no reconstitution or dilution. ... urine, fortified to target levels ... Preservatives including sodium azide have ...
... Liquid Lipid Control is intended for use ... test sample of known concentration for monitoring ... K-ASSAY Liquid Lipid Control with patient serum ... listed constituents. The user can compare observations ...
The K-ASSAY ITA Lyophilized Multi-Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assays for the li...
Medicine Products: